Abstract
Objectives
The aim of this prospective comparative clinical study was to evaluate the effect of oral anticoagulants on peri- and post-operative bleeding during simple single tooth extractions, comparing patients in treatment with vitamin K antagonists (VKAs) and patients assuming direct oral anticoagulants (DOACs).
Materials and methods
Patients under oral anticoagulant therapy needing dental extraction were eligible for entering the study; patients were enrolled following inclusion and exclusion criteria and divided into VKAs and DOAC group according to the anticoagulation therapy. Included patients underwent a simple single dental extraction with elevators and forceps with a maximum surgical time of 15 minutes, without anticoagulation therapy discontinuation. All participants were assessed pre-operatively, during surgery, 30 min minutes and 7 days after surgery. Biological complications were registered and post-extraction bleeding was clinically defined according to Iwabuchi classification. Parametric and non-parametric tests were used to evaluate the variables between the groups.
Results
Sixty-five patients per group were enrolled and 130 teeth were extracted. The two groups were comparable for pre-, peri-, and post-operative variables. Only 1 patient of DOAC group and 2 patients for VKA group needed medical evaluation for post-extractive bleeding. No statistically significant difference resulted in post-operative bleeding events between the groups (p = 0.425).
Conclusions
DOAC and VKA patients showed the same incidence of bleeding complications after simple single tooth extraction. Bleeding events were not statistically significant and not clinically relevant.
Clinical relevance
Patients assuming DOACs can be treated similarly to patients in VKAs therapy with INR index between 2 and 3. Non-ceasing of DOAC therapy seems to be appropriate for simple single dental extractions.
Similar content being viewed by others
References
Caliskan M, Tükel HC, Benlidayi ME, Deniz A (2017) Is it necessary to alter anticoagulation therapy for tooth extraction in patients taking direct oral anticoagulants? Med Oral Patol Oral Cir Bucal 22:767–773
Bauer KA (2013) Pros and cons of new oral anticoagulants. Hematology Am Soc Hematol Educ Program 2013:464–470
Barnes GD, Ageno W, Ansell J, Kaatz S, Subcommittee on the Control of Anticoagulation of the International Society on Thrombosis and Haemostasis (2015) Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH. J Thromb Haemost 13:1154–1156
Mingarro-de-León A, Chaveli-López B (2013) Alternative to oral dicoumarin anticoagulants: considerations in dental care. J Clin Exp Dent 5:273–278
Pollack CVJ, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Steiner T, Wang B, Kam CW, Weitz JI (2015) Idarucizumab for dabigatran reversal. N Engl J Med 373:511–520
Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA (2015) Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med 373:2413–2424
Pengo V (2013) Laboratory tests during direct oral anticoagulant treatment? Yes. Intern Emerg Med 8:371–372
Bacci C, Maglione M, Favero L, Perini A, Di Lenarda R, Berengo M et al (2010) Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, multicentre, prospective, case-control study. Thromb Haemost 104:972–975
Devani P, Lavery KM, Howell CJ (1998) Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary? Br J Oral Maxillofac Surg 36:107–111
Bensi C, Belli S, Paradiso D, Lomurno G (2018) Postoperative bleeding risk of direct oral anticoagulants after oral surgery procedures: a systematic review and meta-analysis. Int J Oral Maxillofac Surg 47:923–932
Lanau N, Mareque J, Giner J, Zabalza M (2017) Direct oral anticoagulants and its implications in dentistry. A review of literature. J Clin Exp Dent 9:1346–1354
Costantinides F, Rizzo R, Pascazio L, Maglione M (2016) Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications. BMC Oral Health 28:16. https://doi.org/10.1186/s12903-016-0170-7
Mauprivez C, Khonsari RH, Razouk O, Goudot P, Lesclous P, Descroix V et al (2016) Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 122:146–155
Lababidi E, Breik O, Savage J, Engelbrecht H, Kumar R, Crossley CW (2018) Assessing an oral surgery specific protocol for patients on direct oral anticoagulants: a retrospective controlled cohort study. Int J Oral Maxillofac Surg 47:940–946
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, Initiative STROBE (2008) The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344–349
Stocco C, Berton F, Papa G, Bussani R, Arnež ZM (2016) Vicryl hypersensitivity test with histological response. Dermatitis 27:145–146
Iwabuchi H, Imai H, Asanami S, Shirakawa M, Yamane GY, Ogiuchi H, Kurashina K, Miyata M, Nakao H, Imai H (2014) Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross-sectional, multicentre, observational study. BMJ 4:e005777. https://doi.org/10.1136/bmjopen-2014-005777
Cohen J (1992) A power primer. Psychol Bull 112:155–159
Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272
Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138:1093–1100
Sharma SD, Vidya B, Alexander M, Deshmukh S (2015) Periotome as an aid to atraumatic extraction: a comparative double blind randomized controlled trial. J Maxillofac Oral Surg 14:611–615
Al-Harbi F, Ahmad I (2018) A guide to minimally invasive crown lengthening and tooth preparation for rehabilitating pink and white aesthetics. Br Dent J 224:228–234
Doganay O, Atalay B, Karadag E, Aga U, Tugrul M (2018) Bleeding frequency of patients taking ticagrelor, aspirin, clopidogrel, and dual antiplatelet therapy after tooth extraction and minor oral surgery. J Am Dent Assoc 149:132–138
Berton F, Stacchi C, Lombardi T, Di Lenarda R (2016) Removal of a maxillary third molar accidentally displaced into the maxillary sinus: presurgical and surgical management. Minerva Stomatol 65:122–124
Miclotte I, Vanhaverbeke M, Agbaje JO, Legrand P, Vanassche T, Verhamme P, Politis C (2017) Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study. Clin Oral Investig 21:2183–2188
Patel JP, Woolcombe SA, Patel RK, Obisesan O, Roberts LN, Bryant C, Arya R (2017) Managing direct oral anticoagulants in patients undergoing dentoalveolar surgery. Br Dent J 222:245–249
Bertozzo G, Zoppellaro G, Granziera S, Marigo L, Rossi K, Petruzzellis F, Perissinotto E, Manzato E, Nante G, Pengo V (2016) Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non-valvular atrial fibrillation. Thromb Haemost 14:2124–2131
Königsbrügge O, Simon A, Domanovits H, Pabinger I, Ay C (2016) Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry. BMC Cardiovasc Disord 16(254):254. https://doi.org/10.1186/s12872-016-0438-5
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F (2017) Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. Thromb Haemost 117:1448–1454
Vene N, Mavri A, Gubenšek M, Tratar G, VižintinCuderman T, PoharPerme M, Blinc A (2016) Risk of thromboembolic events in patients with non-Valvular atrial fibrillation after dabigatran or rivaroxaban discontinuation - data from the Ljubljana registry. PLoS One 11:e0156943. https://doi.org/10.1371/journal.pone.0156943
Gómez-Moreno G, Aguilar-Salvatierra A, Martín-Piedra MA, Guardia J, Calvo-Guirado JL, Cabrera M, López-Gallardo C, Castillo T (2010) Dabigatran and rivaroxaban, new oral anticoagulants. New approaches in dentistry. J Clin Exp Dent 2:1–5
Acknowledgments
The authors wish to thank Alessia Mazzon, Ilaria Benedetti, and Katia Battistuta for the precious work made on the causal periodontal therapy of the enrolled patients. Moreover, a special thanks to the Cardiovascular Center of ASUI Trieste.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Berton, F., Costantinides, F., Rizzo, R. et al. Should we fear direct oral anticoagulants more than vitamin K antagonists in simple single tooth extraction? A prospective comparative study. Clin Oral Invest 23, 3183–3192 (2019). https://doi.org/10.1007/s00784-018-2739-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-018-2739-9